Telmisartan/hydrochlorothiazide

From WikiMD's WELLNESSPEDIA

Telmisartan/hydrochlorothiazide is a medication combination used in the treatment of hypertension. It combines two active ingredients, telmisartan and hydrochlorothiazide, which work together to lower blood pressure.

Etymology[edit]

The name "telmisartan" is derived from the components of the drug: "telmi" is short for telmisartan, and "sartan" refers to the class of drugs known as angiotensin II receptor antagonists. The name "hydrochlorothiazide" is derived from its chemical structure, which includes a hydrochloride group and a thiazide group.

Pharmacology[edit]

Telmisartan is an angiotensin II receptor antagonist that works by blocking the action of angiotensin II, a chemical in the body that causes blood vessels to constrict. This helps to relax and widen blood vessels, reducing blood pressure.

Hydrochlorothiazide is a diuretic that helps the kidneys to remove excess fluid and salt from the body, which can help to lower blood pressure.

Indications[edit]

Telmisartan/hydrochlorothiazide is indicated for the treatment of hypertension in adults who are not adequately controlled on monotherapy with either telmisartan or hydrochlorothiazide, or for those patients who have initially responded to telmisartan and are expected to benefit from combined therapy.

Side Effects[edit]

Common side effects of telmisartan/hydrochlorothiazide include dizziness, fatigue, and headache. More serious side effects can include kidney problems, liver problems, and electrolyte imbalances.

Related Terms[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.